Stereotaxis (STXS) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
TD Cowen Reiterates Buy Rating on Stereotaxis (STXS)
August 13, 2024 6:08 AM EDTTD Cowen analyst Joshua Jennings reiterated a Buy rating and $5.00 price target on Stereotaxis (NYSE: STXS).
The analyst comments "While hospital construction delays caused 2Q system sale weakness, there are now multiple systems in transit to customers. STXS projects 2H revenue... More
Roth/MKM Reiterates Buy Rating on Stereotaxis (STXS)
August 13, 2024 5:07 AM EDTRoth/MKM analyst Jason Wittes reiterated a Buy rating and $5.00 price target on Stereotaxis (NYSE: STXS).
The analyst comments "STXS reported 2Q24 revenue of $4.5 million vs. consensus/our estimate of $5.6 million. System revenue was $0.2 million vs. consensus of $1.3 million and our estimate of $1.5... More



